SESSION VIII. Infections Due to Gram-Negative Bacteria: An Overview
|
|
- Melvin Daniels
- 6 years ago
- Views:
Transcription
1 REVIEWS OF INFECTIOUS DISEASES. VOL. 7, SUPPLEMENT 4 NOVEMBER-DECEMBER by The University of Chicago. All rights reserved /85/ $02.00 SESSION VIII Infections Due to Gram-Negative Bacteria: An Overview Harold C. Neu From the Division of Infectious Disease, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York Infections caused by gram-negative bacteria have continued to be a major problem for hospitalized patients. Malignant necrotizing otitis due to Pseudomonas aeruginosa has been encountered with increasing frequency as the number of older diabetic patients has increased. Nosocomial sinusitis and bacteremia due to Escherichia coli, Klebsiella pneumoniae, Enterobacter species, or P. aeruginosa develop in hospitalized patients. Bacteremia due to E. coli, K. pneumoniae, or P. aeruginosa often follows instrumentation of the urinary, respiratory, or gastrointestinal tracts in the hospitalized patient. Mortality still is excessivelyhigh. Infections of skin structure, particularly decubitus ulcers in debilitated, bedridden patients, are due to a mixed gram-negative and anaerobic flora; frequently, P. aeruginosa and Enterobacteriaceae resistant to many older agents are the major pathogens. Similarly, osteomyelitis in patients who have undergone previous surgical procedures is caused by various multiply resistant Enterobacteriaceae and P. aeruginosa. In all of these situations, therapy has usually included an aminoglycoside. The availability of drugs such as aztreonam, which has activity directed at aerobic gram-negative bacilli, provides an alternative approach that has proved successful and can be evaluated in more detail in the coming years. It is only since the beginning of the 1960s that physicians have adequately appreciated the importance of gram-negative aerobic organisms as pathogens in a significant number of infections outside the urinary tract. The role of aerobic gram-negative bacilli in respiratory and urinary tract infections and in the neutropenic patient are discussed elsewhere in this issue. This overview will review other forms of infection in which aerobic gram-negative organisms have proven to be significant. Upper Respiratory Tract Infections External otitis, which is a superficial infection ofthe external auditory canal, is frequently caused by Pseudomonas aeruginosa. However, in the last decade and a half, a new and important form of external otitis, malignant external otitis, has been encountered with increased frequency [1, 2]. This severeform of external otitis is caused by R aeruginosa. Invasion ofthe cartilage and the external auditory canal Please address requests for reprints to Dr. Harold C. Neu, Department of Medicine, College of Physicians and Surgeons, Division of Infectious Disease, Columbia University, 630 West l68th Street, New York, New York produces osteomyelitis, which if not treated will lead to the developmentofcranial nerve palsies and even to death. Malignant external otitis occurs primarily in diabetic individuals older than 55 years of age. It produces severe pain and tenderness of the tissues around the ear and in the mastoid area of the skull. Successful treatment has involved aggressive surgical removal of devitalized tissue and the extended use of antipseudomonal penicillins - carbenicillin, ticarcillin, azlocillin, or piperacillin- in combination with an aminoglycoside [1-3]. Since the individuals who have this disease frequently have decreased renal function and may already have auditory problems, the use of aminoglycosides may present problems. Would aztreonam be suitable therapy for this disease? Treatment of invasive external otitis with cefsulodin, an antibiotic active primarily against R aeruginosa, has been successful provided thatthe disease has not progressed very far and that the antibiotic is used in conjunction with local debridement [4, 5]. It seems reasonable to suspect that in the future aztreonam will prove useful for treating this unusual infection. However, until a number of patients have been treated, such a statement is mere conjecture. Nosocomial sinusitis has been recognized with in- S778
2 Gram-Negative Infections: An Overview S779 creasing frequency in the last several years [6]. This infection occurs in hospitalized patients who have had nasotracheal tubes or nasogastric tubes in place for a prolonged period. Gram-negative bacteriasuch as Escherichia coli, Klebsiella pneumoniae, or P. aeruginosa may be involved. Indeed, in a study by Kaplan [6], P. aeruginosa was the most frequently isolated pathogen (29070), and P. aeruginosa, Klebsiella species, and Enterobacter speciesaccounted for 63% of the isolates. Although resolution of the sinusitis frequently will follow removal of the nasal tube, in some situations antimicrobial therapy is necessary. An agent such as aztreonam, which would not alter the normal protective streptococcal flora of the oropharynx, may ultimately prove useful in treatment of this nosocomial infection affecting patients in intensive care and trauma units. Infections After Surgery of the Neck A possible use for an agent such as aztreonam would be as therapy for hospital-acquired, gram-negative infections that follow extensive surgery for malignancy of the oropharynx. K. pneumoniae and other Klebsiella species, E. coli, and particularly P. aeruginosa have been the most common pathogens in serious postoperative aerobic wound infections of the neck following cancersurgery [7, 8]. Although aminoglycosides have been used to treat such infections, in viewofthe debilitated state of these patients and the frequency of impaired renal function among them, an agent that would not be nephrotoxic and would not alter normal protective flora-thus decreasing the possibility of overgrowth of fungal and other gram-negative species- would be useful. Obviously, anaerobic bacteria could be involved in such infections, and agents active against grampositive or anaerobic organisms may also be necessary. Sepsis Due to Gram-Negative Bacilli Bacteremia due to gram-negative aerobic bacilli constitutes a major problemin medical and surgical servicesin hospitals throughout the world [9]. Although in some situations bacteremia can be self-limitingparticularly after urinary tract instrumentation in a healthy individual-in many patient populations mortality due to gram-negative bacteremia has remained high [9].Generally, E. coli has been the most common pathogen involved in gram-negative bac- teremia; K. pneumoniae is the next most common pathogen. In recent years, P. aeruginosa has become the third most commonly encountered organism, followed by Enterobacter species and Serratia marcescens [10]. Organisms such as Proteus mirabilis and Providencia (an indole-positive species previously classified as Proteus) are isolated less frequently. Most episodes of gram-negative bacteremia are the result ofdamage or infection in the integument, urinary tract, respiratory tract, or the mucous membranes ofthe gastrointestinal tract. Although many ofthe strains ofe. coli and K. pneumoniae thatproduce bacteremia in patients admitted to the hospital are susceptible to many of the currently available antimicrobial agents, it has become increasingly apparent that organisms which arise within the hospital frequently possess mechanisms that confer resistance to older antimicrobial agents [11]. Hospitalized patients frequently are treated prophylactically with antimicrobial agents or are treated for an infection with antimicrobial agents that alter the normal flora, situations that allow gram-negative bacteria to increase in number, particularly in the intestinal tract. During the past decade, a great deal of work has been devoted to the evaluation of new antimicrobial agents in the therapy for gram-negative bacteremia. The precise role of antimicrobial agents in the decrease in mortality among patients with gramnegative bacteremiaremains a moot question. There have been more aggressive approaches to the diagnosis and the rapid initiation of treatment as well as to the development of supportive and adjunctive measures, all of which contribute significantly to the survival of the patient with gram-negative bacteremia. Since the 1960s, aminoglycosides have been an integral part of the empiric therapy used to treat gram-negative bacteremia [12]. The advent of new cephalosporin antibiotics provided compounds that would yield levels of antibiotic in blood 100-fold or greater than the MIC 90 values for most strains of E. coli and K. pneumoniae and that frequently would yield equally high concentrations against S. marcescens, Proteus species, and Enterobacter species [13]. In this issue the role of aztreonam in therapy for gram-negative bacteremia is reviewed. When the bloodstream isolate is clearly derived from a urinary source, or when the organism has already been defined as gram-negative, the initiationof therapy with aztreonam would seem to be as appropriate as initi-
3 8780 Neu ation with other compounds. However, when the bacteremia may be caused by gram-positive organisms as wellas by gram-negative organisms, it seems appropriate to utilize another agent, which would provide coverage for gram-positive organisms, in combination with aztreonam. Indeed, bacteremia due to gram-positive organisms such as S. pneumoniae, Streptococcus pyogenes, and particularly Staphylococcus aureus can have a clinical presentation similar to that characteristically attributed to bacteremia due to gram-negativebacilli. There is clinical evidence supporting the use of a combination of an antipseudomonal f3-lactam agent with an aminoglycoside for bacteremia due to P. aeruginosa in the neutropenic patient [14]. Further studies will be necessary to clarify the place of aztreonam and aminoglycosides in therapy for such patients. However, the synergy of aztreonam and aminoglycosides against P. aeruginosa in vitro is well established. Biliary Tract Infections The organisms most frequently involvedin acute obstructive cholecystitis and in cholangitis are E. coli, K. pneumoniae, Enterobacter species, and Proteus species [15-17]. Pseudomonas is infrequently encountered, except in patients in whom a catheterhas been placed into the biliary tree to provide drainage and who have acquired a secondary infection. Anaerobic organisms such as Bacteroides, Clostridium, and Fusobacterium are present particularly in patients with chronic forms ofbiliary tract disease [15, 16].The treatment regimen that has been used most frequently in the past has been a combination of clindamycin or metronidazole and an aminoglycoside such as gentamicin or tobramycin. This antimicrobial program is directed primarily at the bacteremia that often complicates cholangitis. Since many of these patients are severely ill and elderly and have a poor fluid balance, it seems that the use of an agent such as aztreonam, which would provide the antibacterial spectrum of an amino glycoside without its associated toxicity, would be appropriate. Levelsof aztreonam in biliary fluid would be adequate to inhibit aerobic gram-negative organisms without causing marked distortion ofthe normal anaerobic flora of the small and large bowel. One must realize that enterococci complicate the tubes draining the biliary tree [17], and since these organisms are not inhibited by aztreonam, secondary infection could occur. Skin and Soft Tissue Infections Cellulitis due to gram-negative aerobic bacteria can occur in the immunocompromised host following trauma. Decubitus ulcers in the chronically debilitated, bedridden patient frequently are due to gramnegative organisms. It is important to realize, however, that anaerobic species probably playa very important role in most infections of the skin structure as well, and the pathologic process is the outcome of the synergistic action of the gram-negative aerobic species and gram-positive cocci and anaerobes [18]. Aminoglycoside antibiotics have characteristically been combined with other agents such as clindamycin or broad-spectrum f3-lactam antibiotics such as cefoxitin, which have activity against gramnegative anaerobes and aerobes, and have been used for treatment of hospital-acquired cellulitis. Such antimicrobial programs frequently result in an alteration in intestinal flora, with further perpetuation of the problem as a result of the selection of resistant microorganisms. It would seem that an agent such as aztreonam would be a possible replacement for the aminoglycoside that has been used in these programs. Obviously, proper care of wounds, including debridement ofdevitalized tissue, is critical and as important as or even more important than the use of antimicrobial agents. In recent years gram-negative aerobic organisms such as P. aeruginosa and various members of the Enterobacteriaceae have been important pathogens in burn-wound sepsis [19]. Although the use of topical silver sulfadiazine or mafenide has reduced the incidence of burn-wound sepsis, the frequent occurrence of severe infection due to gram-negative organisms in burned patients remains a significant problem. Aminoglycosides have been part of the therapeutic regimen for suspected sepsis in burned patients, but since excellentantipseudomonal agents that lack ototoxicity and nephrotoxicity- such as aztreonam - are available, it may be possible to replace the aminoglycoside component of the combination therapy used in these patients. However, it is important to realize that gram-positive infections, particularly those due to S. aureus, are still a problem in burned patients. Indeed, since methicillinresistant strains of S. aureus have become a problem in many burn centers [20], it would be inappropriate to utilize a compound such as aztreonam as a single initial therapeutic agent for the burned patient.
4 Gram-Negative Injections: An Overview S781 Bone and Joint Infections The role ofgram-negative bacteria in infectious arthritis has been recognized in the past few years [21]. Most patients with infectious arthritis due to gramnegative bacilli have had chronic debilitating disease or chronic arthritis in an infected joint and an associated urinary tract infection [22]. In general, infection with gram-negative bacteria has been associated with a poor outcome; and chronic flexion contractures, ankylosing joints, and chronic effusions havebeen a significant problem. Although aminoglycosides enter joint fluid, the activity of these agents at an acid ph in the presence of a large amount of cellular debris is markedly depressed. Therefore, {3-lactam compounds that have activity against gram-negative organisms have generated enthusiasm [23]. Althoughthe number of patients with infectious arthritis due to Enterobacteriaceae or Pseudomonas who have been treated with aztreonam is small, the results have been encouraging. The possibility that aztreonam can be used is particularly important since it can be administered without concern for the toxicity associated with use of the high doses of aminoglycosides that are necessary for clinical efficacy. Osteomyelitis due to gram-negative organisms is seen primarily in patients with underlying malignancy, alcoholism, or other diseases, all of which contribute to the susceptibility of the patient to such infections [24,25]. Surgery or the breach of integument by puncture wounds is frequently the cause of osteomyelitis due to Pseudomonas. Heroin addicts frequently have osteomyelitis due to gram-negative bacteria and S. marcescens [26]. In the majority of series evaluating the treatment ofgram-negative osteomyelitis, the results have been discouraging. The availability of agents such as third-generation cephalosporins or of compounds such as aztreonam provides alternatives to aminoglycoside therapy and its attendant toxicity. Eye Infections Fortunately, endophthalmitis due to gram-negative bacteria is exceedingly uncommon. P. aeruginosa is the organism involved most frequently in eye infections due to gram-negative bacteria; P. mirabilis and S. marcescens infections follow in frequency [28]. The most common organism of all types is S. aureus. Thus, any antibiotic therapy directed at en- dophthalmitis must be one that includes activity against this microorganism. The current data on the concentrations of aztreonam in vitreal fluid are still inadequate. Corneal ulcers caused by Pseudomonas have responded to therapy with gentamicin, and it would seem inappropriate to use aztreonam topically. Conclusions This discussion has been directed at those areas in which gram-negative aerobic bacteriaare important factors in infection. Aminoglycosides have been standard therapy for many of the gram-negative infections discussed in this brief overview. In this symposium, the experience with aztreonam as therapy for infections due to gram-negative bacteria is discussed. Aztreonam has been shown to be effective in many situations. It should be noted that in most trials aztreonam has been directly compared with an aminoglycoside. Are such comparisons trulynecessary? In the therapy for gram-negative bacteremia in the immunocompromised patient, such comparisons will be necessary. In many other areas, however, it seems that an agent with proven efficacy and low toxicity has much to recommend it over the agents currently used, which are known to have intrinsic toxicity. Clearly, the precise role of aztreonam in therapy for gram-negative infections will be established before the end of this decade. References 1. Chandler JR. Malignant external otitis. Laryngoscope 1968; 78: Doroghazi RM, Nadol JB Jr, Hyslop NE Jr, Baker AS, Axelrod L. Invasive external otitis: report of 21 cases and review of the literature. Am J Med 1981;71: Strauss M, Aber RC, Conner GH, Baum S. Malignant external otitis: long-term (months) antimicrobial therapy. Laryngoscope 1982;92: Scully B, Prince A, Ores C, Neu HC. Cefsulodin therapy of Pseudomonas aeruginosa infections: pulmonary and osteomyelitis [abstract no. 69]. In: Program and abstracts of the 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, Mendelson MH, Meyers BR, Hirschman SZ, Shapiro ER, Parisier SC. Treatment of invasive external otitis with cefsulodin. Rev Infect Dis 1984;6(Suppl 3):S Caplan ES, Hoyt NJ. Nosocomial sinusitis. JAMA 1982; 247: JaneckaIP. Maxillofacial infections. Clin Plastic Surg 1979; 6: Becker GO, Parell GJ, Busch OF, Finegold SM, AcquareIIi
5 S782 Neu MJ. Anaerobic and aerobic bacteriology in head and neck cancer surgery. Arch Otolaryngol 1978;104: Bryan CS, Reynolds KL, Brenner ER. Analysis of 1,186episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis 1983;5: Allen JR, Hightower AW, Martin SM, Dixon RE. Secular trends in nosocomial infections: Am J Med 1981;70: Neu HC. Current mechanisms of resistance to antimicrobial agents in microorganisms causing infection in the patient at risk for infection. Am J Med 1984;76(Suppl 5A): Neu HC. Clinical use of aminoglycosides. In: Whelton A, Neu HC, eds. Aminoglycosides: microbiology, clinical use and toxicology. New York: Marcel Dekker, 1982: Neu HC. Do we need the third-generation cephalosporins? J Antimicrob Chemother 1984;14(Suppl B): Young LS. Combination or single drug therapy for gramnegative sepsis. In: Remington JS, Swartz MN, eds. Current clinical topics in infectious disease. Vol. 3. New York: McGraw-Hill, 1982: Lou MA, Mandell AK, Alexander JL, Thadepalli H. Bacteriology of the human biliary tract and the duodenum. Arch Surg 1977;112: Pitt HA, Postier RG, Cameron JL. Biliary bacteria: significance and alterations after antibiotic therapy. Arch Surg 1982;117: Macfarlane JR, BrowneMK. Cholecystectomy wounds: source of infection. J Hosp Infect 1982;3: Stone HH, Martin JD Jr. Synergistic necrotizing cellulitis. Ann Surg 1972;175: Pruitt BA Jr. Burn wound care. Current Problems in Surgery 1979;16(5): Locksley RM, Cohen ML, Quinn TC, Tompkins LS, Coyle MB, Kirihara JM, Counts Gw. Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission and evolution of nosocomial infection. Ann Intern Med 1982;97: Goldenberg DL, Cohen AS. A review of patients with nongonococcal joint infections (with emphasis on therapy and prognosis). Acute infectious arthritis. Am J Med 1976; 60: Goldenberg DL, Brandt KD, Cathcart ES, Cohen AS. Acute arthritis caused by gram-negative bacilli: a clinical characterization. Medicine 1974;53: LeFrock JL, Carr BB. Clinical experience with cefotaxime in the treatment of serious bone and joint infections. Rev Infect Dis 1982;4(Suppl):S Meyers BR, Berson BL, Gilbert M, Hirschman SZ. Clinical patterns of osteomyelitis due to gram-negative bacteria. Arch Intern Med 1973;131: Waldvogel FA, VaseyH. Osteomyelitis: the past decade. N Engl J Med 1980;303: Kido D, Bryan D, Halpern M. Haematogenous osteomyelitis in drug addicts. AJR 1973;118: Sapico FL, Montgomerie JZ. Pyogenic vertebral osteomyelitis: report of nine cases and review of the literature. Rev Infect Dis 1979;1: Allen HE Bacterial endophthalmitis after cataract extraction. In: Bellows JG, ed. Cataract and anomalies of the lens. New York: Grune and Stratton, 1975:421
Appropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationProtein Synthesis Inhibitors
Protein Synthesis Inhibitors Assistant Professor Dr. Naza M. Ali 11 Nov 2018 Lec 7 Aminoglycosides Are structurally related two amino sugars attached by glycosidic linkages. They are bactericidal Inhibitors
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.HNMC.04 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy for important
More informationThe β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationIntra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018
Intra-Abdominal Infections Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Select guidelines Mazuski JE, et al. The Surgical Infection
More informationAn evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage
Journal of Antimicrobial Chemotherapy (1991) 27, Suppl. C, 1-7 An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage J. J. Muscato",
More informationSimilar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.
Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Cephalosporins are divided into Generations: -First generation have better activity against gram positive organisms. -Later compounds
More informationOther Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationAberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015
Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New
More informationGive the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS
Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS Clinical Pharmacy Specialist, Critical Care Dell Seton Medical Center at the University of Texas and Seton Healthcare Family Clinical
More informationSepsis is the most common cause of death in
ADDRESSING ANTIMICROBIAL RESISTANCE IN THE INTENSIVE CARE UNIT * John P. Quinn, MD ABSTRACT Two of the more common strategies for optimizing antimicrobial therapy in the intensive care unit (ICU) are antibiotic
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationAntibiotic Updates: Part II
Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationChapter Anaerobic infections (individual fields): prevention and treatment of postoperative infections
J Infect Chemother (2011) 17 (Suppl 1):62 66 DOI 10.1007/s10156-010-0141-x GUIDELINES Chapter 2-5-1. Anaerobic infections (individual fields): prevention and treatment of postoperative infections Ó Japanese
More informationSecondary bacterial infections complicating skin lesions
J. Med. Microbiol. Vol. 51 (2002), 808 812 # 2002 Society for General Microbiology ISSN 0022-2615 REVIEW ARTICLE Secondary bacterial infections complicating skin lesions ITZHAK BROOK Department of Pediatrics,
More informationThe Effect of Perioperative Use of Prophylactic Antibiotics on Surgical Wound Infection
THE IRAQI POSTGRADUATE MEDICAL JOURNAL PROPHYLACTIC ANTIBIOTICS ON SURGICAL WOUND INFECTION The Effect of Perioperative Use of Prophylactic Antibiotics on Surgical Wound Infection Ahmed Hamid Jasim*, Nabeel
More informationMedicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!
Medicinal Chemistry 561P 2 st hour Examination May 6, 2013 NAME: KEY Good Luck! 2 MDCH 561P Exam 2 May 6, 2013 Name: KEY Grade: Fill in your scantron with the best choice for the questions below: 1. Which
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationAerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune
Original article Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Patil P, Joshi S, Bharadwaj R. Department of Microbiology, B.J. Medical College, Pune, India. Corresponding
More informationPost-operative surgical wound infection
Med. J. Malaysia Vol. 45 No. 4 December 1990 Post-operative surgical wound infection Yasmin Abu Hanifah, MBBS, MSc. (London) Lecturer Department of Medical Microbiology, Faculty of Medicine, University
More informationEpidemiology and Microbiology of Surgical Wound Infections
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2000, p. 918 922 Vol. 38, No. 2 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Epidemiology and Microbiology of Surgical
More informationClinical Policy: Clindamycin (Cleocin) Reference Number: CP.HNMC.08 Effective Date: Last Review Date: Line of Business: Medicaid - HNMC
Clinical Policy: (Cleocin) Reference Number: CP.HNMC.08 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationEmpiric Treatment of Sepsis. Professor of Clinical Microbiology Department of Microbiology Leicester University U. K.
VOL. 38 NO. 8 CHEMO THERAPY Empiric Treatment of Sepsis Emmerson A M Professor of Clinical Microbiology Department of Microbiology Leicester University U. K. Empiric Treatment of Sepsis The treatment of
More informationCentral Nervous System Infections
Central Nervous System Infections Meningitis Treatment Bacterial meningitis is a MEDICAL EMERGENCY. ANTIBIOTICS SHOULD BE STARTED AS SOON AS THE POSSIBILITY OF BACTERIAL MENINGITIS BECOMES EVIDENT, IDEALLY
More informationANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin
ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria
More informationAntimicrobial Prophylaxis in Digestive Surgery
Antimicrobial Prophylaxis in Digestive Surgery Toar JM. Lalisang, MD, PhD Digestive Surgery Division Cipto Mangunkusumo Hospital Medical Faculty Universitas Indonesia Antibiotic must be present before
More information11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1
Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director
More informationESCMID Online Lecture Library. by author
Anaerobic Bacteria in Intra-Abdominal Infections and Bacteremia Maria Hedberg, Umeå University, Umeå, Sweden Anaerobic Bacteria: Next Generation Technology Meets Anaerobic Diagnostics ESCMID Postgraduate
More information4 th and 5 th generation cephalosporins. Naderi HR Associate professor of Infectious Diseases
4 th and 5 th generation cephalosporins Naderi HR Associate professor of Infectious Diseases Classification Forth generation: Cefclidine, cefepime (Maxipime),cefluprenam, cefoselis,cefozopran, cefpirome
More informationAntimicrobial Prophylaxis in the Surgical Patient. M. J. Osgood
Antimicrobial Prophylaxis in the Surgical Patient M. J. Osgood Outline Definitions surgical site infection (SSI) Risk factors Wound classification Microbiology of SSIs Strategies for prevention of SSIs
More informationDiabetic Foot Infection. Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals
Diabetic Foot Infection Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals History of previous amputation [odds ratio (OR)=19.9, P=.01], Peripheral vascular disease (OR=5.5, P=.007)
More informationOverview of Infection Control and Prevention
Overview of Infection Control and Prevention Review of the Cesarean-section Antibiotic Prophylaxis Program in Jordan and Workshop on Rational Medicine Use and Infection Control Terry Green and Salah Gammouh
More informationAntibiotic Abyss. Discussion Points. MRSA Treatment Guidelines
Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California
More informationEnterobacter aerogenes
Enterobacter aerogenes Enterobacter sp. Enterobacter sp. Species: Enterobacter aerogenes Enterobacter agglomerans Enterobacter cloacae causes UTI, enterotoxigenic Often found in the normal intestinal flora,
More informationCost high. acceptable. worst. best. acceptable. Cost low
Key words I Effect low worst acceptable Cost high Cost low acceptable best Effect high Fig. 1. Cost-Effectiveness. The best case is low cost and high efficacy. The acceptable cases are low cost and efficacy
More informationTITLE: NICU Late-Onset Sepsis Antibiotic Practice Guideline
Site: Saint Joseph Hospital - NICU Original Effective Date: 6/1/2016 Next Review Date: 6/1/2019 TITLE: Practice Guideline Purpose: Timely and appropriate treatment of late-onset sepsis with antibiotic
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationnumber Done by Corrected by Doctor Dr.Malik
number 27 Done by Fatimah Farhan Corrected by Basil Al-Bakri Doctor Dr.Malik Note: anything in red is just extra info and you will not be asked about it in the exam. In this sheet we will continue talking
More informationMeasure Information Form
Release Notes: Measure Information Form Version 3.0b **NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE** Measure Set: Pneumonia (PN) Performance Measure Identifier: Measure Information Form
More informationSuper Bugs and Wonder Drugs: Protecting the One While Respecting the Many
Super Bugs and Wonder Drugs: Protecting the One While Respecting the Many Vicki Stringfellow, MSN, CPNP-AC/PC Werner Division of Pediatric Critical Care University of Kentucky Lexington, KY Disclosure
More informationANTIBIOTIC USE GUIDELINES FOR URINARY TRACT AND RESPIRATORY DISEASE
ANTIBIOTIC USE GUIDELINES FOR URINARY TRACT AND RESPIRATORY DISEASE Jane Sykes, BVSc(Hons), PhD, DACVIM (SAIM) School of Veterinary Medicine Dept. of Medicine & Epidemiology University of California Davis,
More informationPrinciples of Infectious Disease. Dr. Ezra Levy CSUHS PA Program
Principles of Infectious Disease Dr. Ezra Levy CSUHS PA Program I. Microbiology (1) morphology (e.g., cocci, bacilli) (2) growth characteristics (e.g., aerobic vs anaerobic) (3) other qualities (e.g.,
More informationDuring the second half of the 19th century many operations were developed after anesthesia
Continuing Education Column Surgical Site Infection and Surveillance Tae Jin Lim, MD Department of Surgery, Keimyung University College of Medicine E mail : tjlim@dsmc.or.kr J Korean Med Assoc 2007; 50(10):
More informationAdequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial
BRIEF REPORT Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial Rodger D. MacArthur, 1 Mark Miller, 2 Timothy Albertson, 3 Edward Panacek, 3
More informationInt.J.Curr.Microbiol.App.Sci (2017) 6(3):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104
More informationRecommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland
Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland A report by the Hospital Antimicrobial Stewardship Working Group, a subgroup of the
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bennett-Guerrero E, Pappas TN, Koltun WA, et al. Gentamicin
More information03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline
Infection Prevention and Control A Foundation Course 2014 What is healthcare-associated infection (HCAI), antimicrobial resistance (AMR) and multi-drug resistant organisms (MDROs)? Why we should be worried?
More informationPharmacology Week 6 ANTIMICROBIAL AGENTS
Pharmacology Week 6 ANTIMICROBIAL AGENTS Mechanisms of antimicrobial action Mechanisms of antimicrobial action Bacteriostatic - Slow or stop bacterial growth, needs an immune system to finish off the microbe
More informationTreatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals
Treatment of Surgical Site Infection Meeting Quality Statement 6 Prof Peter Wilson University College London Hospitals TEG Quality Standard 6 Treatment and effective antibiotic prescribing: People with
More informationQUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)
Pseudomonas aeruginosa (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.) Description: Greenish gray colonies with some beta-hemolysis around each colony on blood agar (BAP),
More informationStudy of Bacteriological Profile of Corneal Ulcers in Patients Attending VIMS, Ballari, India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 7 (2016) pp. 200-205 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.507.020
More informationOverview of Nosocomial Infections Caused by Gram-Negative Bacilli
HEALTHCARE EPIDEMIOLOGY Robert A. Weinstein, Section Editor INVITED ARTICLE Overview of Nosocomial Infections Caused by Gram-Negative Bacilli Robert Gaynes, Jonathan R. Edwards, and the National Nosocomial
More informationCell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017
Cell Wall Inhibitors Assistant Professor Naza M. Ali Lec 3 7 Nov 2017 Cell wall The cell wall is a rigid outer layer, it completely surrounds the cytoplasmic membrane, maintaining the shape of the cell
More informationRETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR
Original article RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR R.Sujatha 1,Nidhi Pal 2, Deepak S 3 1. Professor & Head, Department
More informationAntibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
More informationDrug Class Prior Authorization Criteria Intravenous Antibiotics
Drug Class Prior Authorization Criteria Intravenous Antibiotics Line of Business: Medicaid P&T Approval Date: August 15, 2018 Effective Date: October 1, 2018 This drug class prior authorization criteria
More informationMicrobiology ( Bacteriology) sheet # 7
Microbiology ( Bacteriology) sheet # 7 Revision of last lecture : Each type of antimicrobial drug normally targets a specific structure or component of the bacterial cell eg:( cell wall, cell membrane,
More informationKonsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program
Konsequenzen für Bevölkerung und Gesundheitssysteme Stephan Harbarth Infection Control Program University of Geneva Hospitals Outline Introduction What data sources are available? AMR-associated outcomes
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationRole of the nurse in diagnosing infection: The right sample, every time
BROUGHT TO YOU BY Role of the nurse in diagnosing infection: The right sample, every time The module has been written by Shanika Anne-Marie Crusz and Amelia Joseph Authors affiliation: Department of Clinical
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationAppropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases
Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses
More informationSource: Portland State University Population Research Center (
Methicillin Resistant Staphylococcus aureus (MRSA) Surveillance Report 2010 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Health Authority Updated:
More informationCLINICAL USE OF BETA-LACTAMS
CLINICAL USE OF BETA-LACTAMS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu WHY IS INFECTIOUS DISEASE PHARMACOTHERAPY SO CONFUSING? Microbial
More informationVCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS
VCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS CARDIAC Staphylococcus aureus, S. epidermidis, except for For patients with known MRSA colonization, recommend decolonization with Antimicrobial Photodynamic
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More informationAuthor - Dr. Josie Traub-Dargatz
Author - Dr. Josie Traub-Dargatz Dr. Josie Traub-Dargatz is a professor of equine medicine at Colorado State University (CSU) College of Veterinary Medicine and Biomedical Sciences. She began her veterinary
More informationIn Vitro Activity of Netilmicin, Gentamicin, and Amikacin
ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Jan. 1977, p. 126-131 Copyright X 1977 American Society for Microbiology Vol. 11, No. 1 Printed in U.S.A. In Vitro Activity of Netilmicin, Gentamicin, and Amikacin
More informationNo-leaching. No-resistance. No-toxicity. >99.999% Introducing BIOGUARD. Best-in-class dressings for your infection control program
Introducing BIOGUARD No-leaching. >99.999% No-resistance. No-toxicity. Just cost-efficient, broad-spectrum, rapid effectiveness you can rely on. Best-in-class dressings for your infection control program
More informationCipro for gram positive cocci in urine
Buscar... Cipro for gram positive cocci in urine 20-6-2017 Pneumonia can be generally defined as an infection of the lung parenchyma, in which consolidation of the affected part and a filling of the alveolar
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationIntra-abdominal anaerobic infections. Diagnostics and therapy
Intra-abdominal anaerobic infections. Diagnostics and therapy Elisabeth Nagy MD. PhD. DSc. Institute of Clinical Microbiology, Faculty of Medicine, University of Szeged 4th ESCMID School, Szeged, Hungary
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More information** the doctor start the lecture with revising some information from the last one:
Page 1 of 7 ** the doctor start the lecture with revising some information from the last one: #penicillin G has a good susceptibility against gram(+ve), Neisseria (-ve) #mostly active against strep. (don
More informationMicrobiology of War Wounds AUBMC Experience
Microbiology of War Wounds AUBMC Experience Abdul Rahman Bizri MD MSc Division of Infectious Diseases Department of Internal Medicine AUBMC Conflict Medicine Program - AUB Current Middle- East Geopolitical
More informationLearning Points. Raymond Blum, M.D. Antimicrobial resistance among gram-negative pathogens is increasing
Raymond Blum, M.D. Learning Points Antimicrobial resistance among gram-negative pathogens is increasing Infection with antimicrobial-resistant pathogens is associated with increased mortality, length of
More informationIntroduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018
Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationTHERAPY OF ANAEROBIC INFECTIONS LUNG ABSCESS BRAIN ABSCESS
THERAPY OF ANAEROBIC INFECTIONS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu LUNG ABSCESS A lung abscess is a localized pus cavity in
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationSecondary peritonitis
Secondary peritonitis Caused by spillage of gastrointestinal microorganisms into the peritoneal cavity secondary to loss of the integrity of the mucosal barriers Etiology: perforation of peptic ulcer traumatic
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationProphylactic antibiotic timing and dosage. Dr. Sanjeev Singh AIMS, Kochi
Prophylactic antibiotic timing and dosage Dr. Sanjeev Singh AIMS, Kochi Meaning - Webster Medical Definition of prophylaxis plural pro phy lax es \-ˈlak-ˌsēz\play : measures designed to preserve health
More informationمادة االدوية المرحلة الثالثة م. غدير حاتم محمد
م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:
More informationAntimicrobial Selection and Therapy for Equine Musculoskeletal Trauma
Antimicrobial Selection and Therapy for Equine Musculoskeletal Trauma Lucio Petrizzi DVM DECVS Università degli Studi di Teramo Surgical site infections (SSI) Microbial contamination unavoidable Infection
More information4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES
CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial
More informationResponsible use of antibiotics
Responsible use of antibiotics Uga Dumpis MD, PhD Department of Infectious Diseases and Infection Control Pauls Stradiņs Clinical University Hospital Challenges in the hospitals Antibiotics are still effective
More informationInternational Journal of Research in Pharmacology & Pharmacotherapeutics
International Journal of Research in Pharmacology & Pharmacotherapeutics ISSN Print: 2278 2648 IJRPP Vol.3 Issue 3 July-Sep-214 ISSN Online: 2278-2656 Journal Home page: Research article Open Access Study
More informationTreatment of septic peritonitis
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Treatment of septic peritonitis Author : Andrew Linklater Categories : Companion animal, Vets Date : November 2, 2016 Septic
More informationCombination vs Monotherapy for Gram Negative Septic Shock
Combination vs Monotherapy for Gram Negative Septic Shock Critical Care Canada Forum November 8, 2018 Michael Klompas MD, MPH, FIDSA, FSHEA Professor, Harvard Medical School Hospital Epidemiologist, Brigham
More informationHospital-acquired pneumonia (HAP) is the second
Guidelines and Critical Pathways for Severe Hospital-Acquired Pneumonia* Stanley Fiel, MD, FCCP Hospital-acquired pneumonia (HAP) is associated with high morbidity and mortality. Early, appropriate, and
More informationBacteriology of Surgical Site Infections and Antibiotic Susceptibility Pattern of the Isolates at a Tertiary Care Hospital in Karachi
Abstract Bacteriology of Surgical Site Infections and Antibiotic Susceptibility Pattern of the Isolates at a Tertiary Care Hospital in Karachi Abid Mahmood ( Department of Pathology, PNS Shifa, Karachi.
More informationAntimicrobial susceptibility
Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL
More information